We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

6 hedge funds and large institutions have $775K invested in China Pharma Holdings in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

100% more funds holding

Funds holding: 3 → 6 (+3)

50% more capital invested

Capital invested by funds: $518K → $775K (+$257K)

0% more ownership

Funds ownership: 0% → 0.01% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$116K
2
HF
HRT Financial
New York
+$29.4K
3
TI
tru Independence
Oregon
+$6.17K
4
TSS
Two Sigma Securities
New York
+$5.92K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$55.3K
2
UBS Group
UBS Group
Switzerland
-$23.7K
3
Citadel Advisors
Citadel Advisors
Florida
-$11K

CPHI Hedge Fund Activity: Q2 2020 in Review

6 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2020, worth a combined $775K — up 50% from $518K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CPHI positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $116K. The largest seller was Renaissance Technologies, cutting an estimated $55.3K.

  • 6 institutional investors held China Pharma Holdings (CPHI) as of Q2 2020, up from 3 in Q1 2020.
  • Funds reported $775K of China Pharma Holdings stock for Q2 2020, up 50% quarter-over-quarter.
  • 4 funds opened new China Pharma Holdings positions in Q2 2020 and 1 closed out, a net change of +3 holders.
  • The largest China Pharma Holdings buyer in Q2 2020 was Bridgeway Capital Management, an estimated $116K added.
  • The largest China Pharma Holdings seller in Q2 2020 was Renaissance Technologies, an estimated $55.3K sold.

Based on aggregated 13F filings for Q2 2020.